| 25(OH)D | 25-hydroxyvitamin D |
| 27-OHC | 27-hydroxycholesterol |
| 5LO | 5-lipoxygenase |
| AA | Anthranilic acid |
| AD | Alzheimer’s disease |
| ADMA | Asymmetric dimethylarginine |
| ALA | Alpha-lipoic acid |
| ApoE | Apolipoprotein E |
| APP | Amyloid precursor protein |
| Aβ | Amyloid β |
| BBB | Blood–brain barrier |
| BHMT | Betaine-homocysteine methyltransferase |
| CBF | Cerebral blood flow |
| cECs | Cerebral endothelial cells |
| CH2THF | 5,10-Methylenetetrahydrofolate |
| CH3THF | 5-methyltetrahydrofolate |
| CNS | Central nervous system |
| COMT | Catechol-O-methyltransferase |
| CSF | Cerebrospinal fluid |
| DDAH | Dimethylarginine dimethylaminohydodrolase |
| DMA | Dimethylamine |
| DMG | Dimethylglycine |
| DM-PP2Ac | De-methylated PP2A catalytic subunit |
| DR4/5 | Death receptor 4 and 5 |
| EAE | Autoimmune encephalomyelitis |
| EDSS | Expanded Disability Status Score |
| ET | Endothelin |
| FAD | Flavin adenine dinucleotide |
| HAA | 3-hydroxyanthranilic acid |
| HCs | Healthy controls |
| HCTL | Homocysteine thiolactone |
| Hcy | Homocysteine |
| HHcy | Hyperhomocysteinemia |
| HK | 3-hydroxykynurenine |
| iNOS | inducible Nitric Oxide Synthase |
| KA | Kynurenic acid |
| KAT | Kynurenine aminotransferase |
| Kyn | kynurenine |
| KYNU | Kynureninase |
| MBP | Myelin basic protein |
| MCI | Mild Cognitive Impairment |
| MeSe | Methionine synthase |
| MMA | Methylmalonic acid |
| MOG | Myelin oligodendrocyte glycoprotein |
| M-PP2Ac | Methylated PP2A catalytic subunit |
| MS | Multiple sclerosis |
| MSSS | Multiple Sclerosis Severity Score |
| MTHFR | Methylenetetrahydrofolate reductase |
| NMO | Neuromyelitis optica |
| NO | Nitric oxide |
| NOS | Nitric oxide synthase |
| ONDs | Other neurologic diseases |
| PD | Parkinson’s disease |
| PLP | Pyridoxal 5-phosphate |
| PP2A | Protein phosphatase 2A |
| PRMT-1 | Protein arginine methyltransferases-1 |
| PRMT-4 | Protein arginine methyltransferase-4 |
| PS1 | Presenilin 1 |
| pS262-tau | Ser262 hyperphosphorylated tau |
| PTMs | Post-translational modifications |
| ROS | Reactive oxygen species |
| RR | Relapsing–remitting |
| SAH | S-adenosyl homocysteine |
| SAM | S-adenosyl methionine |
| SDMA | Symmetric dimethylarginine |
| SP | Secondary progressive |
| TCA | Tricarboxylic acid |
| THF | Tetrahydrofolate |
| tHcy | Total homocysteine |
| VCID | Cognitive impairment and dementia |
| XA | Xanthurenic acid |